The Pennant Group, Inc. (PNTG)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.39	24.25	6.06	2.08	5.19	0.04
Cash & Short-Term Investments	14.39	24.25	6.06	2.08	5.19	0.04
Cash Growth	372.72%	300.17%	191.44%	-59.94%	11969.77%	-89.30%
Accounts Receivable	95.72	81.3	61.12	53.42	53.94	47.22
Other Receivables	-	0.21	0.24	-	-	-
Receivables	95.72	81.51	61.35	53.42	53.94	47.22
Prepaid Expenses	17.27	17.1	12.67	18.32	16.71	12.34
Total Current Assets	127.37	122.86	80.08	73.82	75.84	59.6
Property, Plant & Equipment	326.42	313.88	291.52	287.49	317.79	326.53
Goodwill	156.6	129.12	91.01	79.5	74.27	66.44
Other Intangible Assets	117.18	96.18	67.74	58.62	53.73	47.49
Long-Term Deferred Tax Assets	0.03	-	-	2.15	3.85	2.1
Other Long-Term Assets	20.33	17.48	9.34	10.55	4.83	4.81
Total Assets	751.42	679.52	539.69	512.12	530.3	506.98
Accounts Payable	19.21	18.74	10.84	13.65	10.55	9.76
Accrued Expenses	52.85	52.35	36.55	30.34	29.09	32.8
Current Portion of Leases	21.02	19.67	17.12	16.63	16.12	14.11
Current Unearned Revenue	2.12	2.28	1.66	1.59	7.67	24.04
Other Current Liabilities	6.68	8.66	5.37	8.04	8.21	8.31
Total Current Liabilities	104.94	101.7	71.55	70.25	71.64	89.02
Long-Term Debt	37	-	63.91	62.89	51.37	8.28
Long-Term Leases	261.54	253.42	248.6	247.04	287.75	296.62
Long-Term Deferred Tax Liabilities	1.14	1.86	1.86	-	-	-
Other Long-Term Liabilities	13.16	10.58	8.26	6.28	5.29	11.9
Total Liabilities	417.79	367.56	394.18	386.46	416.05	405.8
Common Stock	0.04	0.04	0.03	0.03	0.03	0.03
Additional Paid-In Capital	241.25	236.09	105.71	99.76	95.6	84.67
Retained Earnings	72.08	57.22	34.66	21.28	14.64	11.95
Treasury Stock	-0.07	-0.07	-0.07	-0.07	-0.07	-0.07
Total Common Equity	313.3	293.28	140.34	121.01	110.2	96.58
Minority Interest	20.33	18.68	5.18	4.65	4.05	4.59
Shareholders' Equity	333.63	311.97	145.52	125.66	114.24	101.17
Total Liabilities & Equity	751.42	679.52	539.69	512.12	530.3	506.98
Total Debt	319.57	273.09	329.63	326.57	355.24	319
Net Cash (Debt)	-305.18	-248.85	-323.57	-324.49	-350.05	-318.96
Net Cash Per Share	-8.88	-7.78	-10.72	-10.76	-11.42	-10.55
Filing Date Shares Outstanding	34.56	34.43	30.01	29.71	28.53	28.26
Total Common Shares Outstanding	34.78	34.67	30.29	30.15	28.5	28.24
Working Capital	22.43	21.16	8.53	3.58	4.21	-29.42
Book Value Per Share	9.01	8.46	4.63	4.01	3.87	3.42
Tangible Book Value	39.52	67.98	-18.42	-17.1	-17.8	-17.35
Tangible Book Value Per Share	1.14	1.96	-0.61	-0.57	-0.62	-0.61
Land	7.67	5.63	0.1	0.1	-	-
Buildings	14.07	8.78	1.89	1.89	-	-
Machinery	37.24	32.74	29.22	26.68	23.61	23.61
Construction In Progress	2.31	2.72	1.26	-	-	-
Leasehold Improvements	23.64	21.88	21.2	18.76	11.66	9.98

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q